GemOx or GEMOX is an acronym for one of the chemotherapy regimens, used in the treatment of relapsed or primary refractory non-Hodgkin's lymphoma and Hodgkin disease.
When combined with Rituximab it is called R-GemOx, R-GEMOX or GemOx-R, GEMOX-R.
The [R]-GemOx regimen consists of:
- (R)ituximab - anti-CD20 monoclonal antibody that has the ability to kill both normal and malignant B cells;
- (Gem)citabine - an antimetabolite;
- (Ox)aliplatin - a platinum-based antineoplastic agent with alkylating mechanism of action.
References
GemOx Wikipedia(Text) CC BY-SA